Hjem › Endometriekreft › Arkansas › Little Rock
Kliniske studier for Endometriekreft i Little Rock, AR
10 studier for Endometriekreft søker deltakere på steder i og rundt Little Rock (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekruttererFase 3
- University of Arkansas for Medical Sciences, Little Rock
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- University of Arkansas Medical School, Little Rock
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
RekruttererFase 1
- University of Arkansas Winthrop P. Rockefeller Cancer Institute, Little Rock
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekruttererFase 3
- Research Site, Little Rock
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RekruttererFase 2
- University of Arkansas for Medical Sciences, Little Rock
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
RekruttererFase 1
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruttererFase 1
- University of Arkansas, Little Rock
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
RekruttererFase 2
- Michael Birrer, MD, PhD, Little Rock
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Little Rock
Endometriekreft-studier i andre byer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
Andre studier i Little Rock
- Schizofreni19 studier
- Kreft (alle typer)14 studier
- Major depresjon14 studier
- Akut myelogen leukemi13 studier
- Ikke-småcellet lungekreft13 studier
- Fedme11 studier
- Depresjon10 studier
- Type 2-diabetes10 studier
- Lungekreft9 studier
- Kardiovaskulær sykdom9 studier
- Blærekreft9 studier
- Hjertesvikt9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.